Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate in Chronic Fatigue Syndrome
NCT01584934Phase 4Withdrawn
- Sponsor
- Ghent University Hospital
- Start
- Jun 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium oxybate in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by Ghent University Hospital. Planned start Jun 2013; status: withdrawn.
02
Drugs
sodium oxybate
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT01584934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01584934.